Company: LNAI
Filing Date: 2025-02-19
Form Type: 10-K/A
Source: 0001731122-25-000252
Chunk: 157

Company: Lunai Bioworks Inc.
Filing Date: 2025-02-19
Form: 10-K/A
Chunk 157
---
 terminated $468,453 in
aggregate principal amount and interest accrued thereon of a convertible promissory note issued in 2023 and paid in cash an aggregate
amount of $66,000 to the Company in consideration for the Units.

In relation to the June 14, 2024 Private Placement the Company recognized
a loss on the settlement of debt for $1,183,560 which was recorded in other income (expense) in the statement of operations for the year
ended June 30, 2024.

F-27

Common Stock Issuances

On April 5, 2024, the Company issued 33,760 shares
of common stock for consulting services valued at $94,190.

On February 20, 2024, 2,953,700
warrants outstanding were exercised at prices ranging from $0.53 to $0.65 per share and the aggregate $1,750,000 of a promissory note
held by the holder was applied to the exercise price of the warrants (see Note 8).

On February 20, 2024, 471,699 warrants
outstanding were exercised at $0.53 per share valued at $250,000. A promissory note held by the holder was applied to the exercise
price of the warrants in lieu of cash proceeds (see Note 9).

On February 15, 2024, the Company
issued 50,000 shares of Common Stock for consulting services valued at $100,000.

On February 15, 2024, the Company closed a private placement of 344,827shares of Common Stock, $ 0.0001par value, at $2.90 per share for aggregate proceeds to the Company of $ 1,000,000in cash.

On February 16, 2024, the Company
recognized3,425,399 shares of common stock to be issued in settlement of the contingent consideration as a result of the Company’s
acquisition of GEDi Cube Intl Ltd. As further described in Note 12.

On February 13, 2024, the Company issued 70,834,183valued at $ 136,001,631(see Note 13) shares of Common Stock pursuant to the Stock Purchase Agreement of Renovaro Cube.

On December 4, 2023, the Company
issued 525,945 shares of Common Stock pursuant to warrants exercised for cash proceeds of $341,865.